Alaunos Therapeutics Inc.
TCRT | NASDAQ
$1.26
+$0.06 (+5.00%)
At close: Sep 21, 2026, 4:00 PM ET
$1.29
+$0.03 (+2.73%)
Pre-market:
Sep 22, 2026, 6:31 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3K | 3K | 5K | 6K | 6K | 10K | 9K | 6K | 6K | 6K | 5K | 15K | 2.93M | 2.92M | 2.92M | 2.91M | 398K | 398K | 398K | 398K | n/a | n/a |
Cost of Revenue | 838K | 1.02M | 1.36M | 1M | 675K | 670K | 325K | 1.26M | 2.18M | 7.19M | 7.88M | 10.05M | 9.68M | 5.18M | 5.17M | 2.77M | 14.4M | 14.39M | 14.25M | 13.54M | 1.22M | 540K |
Gross Profit | -835K | -1.02M | -1.36M | -995K | -669K | -660K | -316K | -1.25M | -2.17M | -7.18M | -7.87M | -10.04M | -6.75M | -2.26M | -2.25M | 141K | -14M | -14M | -13.85M | -13.14M | -1.22M | -540K |
Operating Income | -4.06M | -4.14M | -4.22M | -4.07M | -4.04M | -4.16M | -4.81M | -12.01M | -18.09M | -24.91M | -32.84M | -33.41M | -34.44M | -35.82M | -35.24M | -36.91M | -50.94M | -64.21M | -76.69M | -89.27M | -87.3M | -83.26M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7K | 7K |
Pretax Income | -4.01M | -4.11M | -4.18M | -4.03M | -3.99M | -4.07M | -4.68M | -11.78M | -19.13M | -26.77M | -35.14M | -36.46M | -36.83M | -37.99M | -37.73M | -40.37M | -54.25M | -66.99M | -78.75M | -89.73M | -87.31M | -83.24M |
Net Income | -4.01M | -4.11M | -4.18M | -4.03M | -3.99M | -4.07M | -4.68M | -11.78M | -19.13M | -26.77M | -35.14M | -36.46M | -36.83M | -37.99M | -37.73M | -40.37M | -54.25M | -66.99M | -78.75M | -89.73M | -87.31M | -83.24M |
Selling & General & Admin | 2.42M | 2.71M | 2.87M | 3.16M | 3.45M | 3.59M | 4.46M | 6.04M | 7.55M | 9.6M | 10.46M | 10.96M | 11.03M | 10.73M | 11.08M | 9.54M | 13.82M | 19.47M | 24.34M | 31.75M | 31.23M | 29.4M |
Research & Development | 1.65M | 1.44M | 1.36M | 915K | 589K | 584K | 363K | 1.38M | 4.9M | 9.9M | 16.28M | 20.95M | 25.19M | 25.94M | 25.02M | 27.51M | 34.13M | 41.77M | 49.52M | 55.4M | 54.85M | 53.33M |
Other Expenses | -838K | -1.02M | -1.36M | -1M | -675K | -670K | -323K | 3.33M | 3.48M | -1.78M | -1.78M | -8.54M | -8.54M | -3.11M | -3.11M | n/a | -11.02M | -11.02M | -11.02M | -11.02M | 8K | 18K |
Operating Expenses | 3.22M | 3.12M | 2.87M | 3.08M | 3.37M | 3.5M | 4.5M | 10.76M | 15.92M | 17.73M | 24.96M | 23.37M | 27.69M | 33.57M | 32.99M | 37.05M | 36.94M | 50.22M | 62.84M | 76.13M | 86.08M | 82.72M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.07M | 1.92M | 2.81M | 3.65M | 3.32M | 3.15M | 3M | 2.61M | 1.9M | 1.21M | 475K | 31K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -2K | -2K | -2K | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -18.86M | -18.86M | -18.86M |
Cost & Expenses | 3.11M | 4.15M | 4.23M | 4.08M | 4.04M | 4.17M | 4.82M | 12.01M | 18.1M | 24.91M | 32.84M | 33.42M | 37.37M | 38.75M | 38.16M | 39.82M | 51.34M | 64.61M | 77.09M | 89.67M | 87.3M | 83.26M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.43M | 1.95M | 1.95M | 2.18M | 1.68M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.49M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M |
Shares Outstanding (Diluted) | 2.43M | 1.95M | 1.95M | 2.18M | 1.68M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M | 1.49M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M |
EPS (Basic) | -1.95 | -2.17 | -2.25 | -2.31 | -2.46 | -2.54 | -2.92 | -7.36 | -11.96 | -16.74 | -21.54 | -23.22 | -24.50 | -25.85 | -27.32 | -28.98 | -38.29 | -47.31 | -55.10 | -62.89 | -61.32 | -58.57 |
EPS (Diluted) | -1.95 | -2.17 | -2.25 | -2.31 | -2.46 | -2.54 | -2.92 | -7.36 | -11.96 | -16.74 | -21.54 | -23.22 | -24.50 | -25.85 | -27.32 | -28.98 | -38.29 | -47.31 | -55.10 | -62.89 | -61.32 | -58.57 |
EBITDA | -4M | -4.09M | -4.17M | -4.02M | -3.99M | -4.07M | -4.68M | -7.05M | -13.34M | -19.74M | -26.56M | -28.77M | -28.67M | -29.65M | -29.57M | -34.59M | -48.89M | -62.37M | -74.97M | -86.97M | -85.35M | -81.71M |
EBIT | -3.06M | -4.11M | -4.18M | -4.03M | -3.99M | -4.07M | -4.68M | -7.3M | -14.65M | -21.75M | -29.26M | -31.92M | -31.45M | -32.42M | -32.33M | -37.36M | -51.64M | -65.12M | -77.57M | -89.29M | -87.32M | -83.26M |
Depreciation & Amortization | 15K | 15.5K | 7.5K | -501 | -501 | n/a | 2K | 244K | 1.31M | 2.01M | 2.7M | 3.15M | 2.78M | 2.77M | 2.76M | 2.77M | 2.75M | 2.75M | 2.6M | 2.31M | 1.96M | 1.53M |
Add to Watchlist
Select watchlists to add or remove TCRT